About Chipcare
Chipcare is a company based in Toronto (Canada) founded in 2009. It operates as a B2B. Chipcare has raised $11.1 million across 3 funding rounds from investors including University of Toronto, Canadian Space Agency and Grand Challenges Canada. Chipcare operates in a competitive market with competitors including Souzhou Ribo Life Science, PathoQuest, Quantalife, Chembio and Senzo, among others.
- Headquarter Toronto, Canada
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.1 M (USD)
in 3 rounds
-
Latest Funding Round
$2.8 M (USD), Series B
Nov 17, 2016
-
Investors
University of Toronto
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Chipcare
Chipcare has successfully raised a total of $11.1M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $2.8 million completed in November 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $2.8M
-
First Round
First Round
(17 Sep 2013)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2016 | Amount | Series B - Chipcare | Valuation |
investors |
|
| Mar, 2015 | Amount | Series A - Chipcare | Valuation |
investors |
|
| Sep, 2013 | Amount | Seed - Chipcare | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Chipcare
Chipcare has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include University of Toronto, Canadian Space Agency and Grand Challenges Canada. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage health science technologies are developed into business ventures by TIAP.
|
Founded Year | Domain | Location | |
|
Angel investment network based in Toronto supporting Canadian startups.
|
Founded Year | Domain | Location | |
|
Biotech Alliances is engaged in life science strategic advisory.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Chipcare
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Chipcare
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Chipcare Comparisons
Competitors of Chipcare
Chipcare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Souzhou Ribo Life Science, PathoQuest, Quantalife, Chembio and Senzo, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nucleic acid drugs are developed via RNA interference technology.
|
|
| domain | founded_year | HQ Location |
Next-generation sequencing is provided for microbiology testing applications.
|
|
| domain | founded_year | HQ Location |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
|
|
| domain | founded_year | HQ Location |
Proprietary immunoassay platform is utilized for infectious disease diagnostics.
|
|
| domain | founded_year | HQ Location |
Point-of-care diagnostic devices for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Biopreservation platform for mammalian cells and biologics is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Chipcare
When was Chipcare founded?
Chipcare was founded in 2009 and raised its 1st funding round 4 years after it was founded.
Where is Chipcare located?
Chipcare is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Is Chipcare a funded company?
Chipcare is a funded company, having raised a total of $11.1M across 3 funding rounds to date. The company's 1st funding round was a Seed of $3.25M, raised on Sep 17, 2013.
What does Chipcare do?
Chipcare, backed by 11095000.0 from Biotech Alliances International, TIAP, Maple Leaf Angels, Epic Capital Wealth Management, University of Toronto, Grand Challenges Canada, Canadian Space Agency, focuses on providing healthcare solutions, developing medical devices, offering diagnostic solutions, and blood testing. Develops a hand-held blood test device from a single drop of blood. Driving innovation, growth, and excellence in its industry sectors.
Who are the top competitors of Chipcare?
Chipcare's top competitors include Souzhou Ribo Life Science, Chembio and Quantalife.
Who are Chipcare's investors?
Chipcare has 7 investors. Key investors include University of Toronto, Canadian Space Agency, Grand Challenges Canada, Biotech Alliances, and TIAP.